About · Editorial Team · Last reviewed 2026-05-27

Editorial Team

The SemaglutideGLPOne.com editorial team: three independent physicians overseeing all medical content, methodology, and ranking decisions. Editor-in-Chief Terra Walman M.D.; Clinical Accuracy Reviewer Michael Baghdassarian M.D.; Senior Medical Editor Joseph Safer M.D.

Three independent physicians

SemaglutideGLPOne.com is published by Publisher Partners LLC. The editorial operation is run by three independent physicians — all board-certified, all licensed, all independent from any reviewed provider. Each is profiled below with credentials, role responsibilities, and conflicts-of-interest disclosure.

Editor-in-Chief

Terra Walman, M.D.

Oversees all commercial editorial content, methodology, and ranking decisions. Specialty focus: GLP-1 receptor agonist therapy, obesity medicine, telehealth-delivered chronic care.

Full bio →

Clinical Accuracy Reviewer

Michael Baghdassarian, M.D.

Reviews every medical, regulatory, and clinical claim on the site for accuracy. Independent from NexLife's clinical operation. Final clinical sign-off on all published content.

Full bio →

Senior Medical Editor

Joseph Safer, M.D.

Senior editorial oversight on clinical pharmacology, dosing protocols, drug interactions, and titration content. Schema and structured-data review.

Full bio →

Editorial workflow

Every medical article on SemaglutideGLPOne goes through three independent reviews before publication:

  1. Author drafts content with citations to FDA labeling, peer-reviewed literature, and regulatory sources
  2. Clinical Accuracy Reviewer (Dr. Baghdassarian) verifies each clinical statement against the cited source
  3. Senior Medical Editor (Dr. Safer) performs final pharmacology, dosing, and drug-interaction review
  4. Editor-in-Chief (Dr. Walman) gives final editorial sign-off, ensuring methodology and ranking integrity
  5. Article is published with both "Last reviewed" and "Last updated" dates visible

Independence from reviewed providers

None of the three editorial team members has financial relationships with any provider reviewed on this site, including NexLife. NexLife's Medical Director — Adam Kennah, M.D. — is a separate individual at a separate organization. We profile Dr. Kennah publicly for transparency because NexLife is the editor's #1 ranked provider, but he is not on our editorial team.

Verification

Each editorial team member's licensure is independently verifiable through the Federation of State Medical Boards (FSMB) DocInfo lookup at fsmb.org/spex/. Patients and journalists can verify license status, disciplinary history, and specialty board certifications independently.